Literature DB >> 3609127

Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus.

S Petrenko, M C Olianas, P Onali, G L Gessa.   

Abstract

Neuropeptide Y inhibited the forskolin-stimulated adenylate cyclase activity in rat hippocampus with the half-maximal effect occurring at 73 nM. The maximal inhibition corresponded to a 17-22% decrease of the control level of enzyme activity. The effect of neuropeptide Y was mimicked by the peptide YY but not by the avian pancreatic polypeptide and required micromolar concentrations of GTP. These results indicate that, in the brain, the inhibition of adenylate cyclase activity constitutes a mechanism by which the receptor for neuropeptide Y transduces its signal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609127     DOI: 10.1016/0014-2999(87)90318-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide.

Authors:  E Schlicker; G Gross; K Fink; T Glaser; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

2.  Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium.

Authors:  H M Cox; A W Cuthbert
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

4.  Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.

Authors:  S Foucart; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.